News Data privacy concerns don't hinder digital health app usage A new survey conducted by juli, an AI-powered chronic condition platform, has revealed that the value placed on
Views & Analysis New IFPMA and EFPIA guidance on use of social media by the p... On 28 September 2022, the international and European self-regulatory bodies for the research-based pharmaceutical industry (I
Views & Analysis The power of self-management to target gaps in chronic disea... The time of healthcare professionals is limited, but systems often rely on them as the principal means to help patients with chronic diseases.
Sales & Marketing Making data work by delivering relevant content to HCPs Healthcare providers (HCPs) are facing a digital deluge and successive studies reveal that most messaging gets lost in the flood. The torrent of ill-directed communication and ill-
Sales & Marketing Measuring success in pharma marketing: Does engagement equat... Is engagement the equivalent of a “digital smile” in pharma marketing, or have we been measuring communications efficacy all wrong?
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
